Clinical Trial

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

Name: A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors — clinical trial record (NCT07466160)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study was designed to evaluate the efficacy and safety of 7MW3711 in combination with JS207 in subjects with solid tumor.

Trial Details

NCT Number	NCT07466160
Lead Sponsor	Mabwell (Shanghai) Bioscience Co., Ltd.
Conditions	Solid Tumor
Enrollment	280 participants
Start Date	2026-02-11
Primary Completion	2027-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-03-12